Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.

At ECR 2026, UII reaffirmed its AI development principles, which are anchored in clinical validation, regulatory rigor, and measurable outcomes. This approach transforms radiology knowledge into a ...

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services ConferenceCompany to Present and Host 1x1 Investor Meetings on ...

Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...

As Liz Cantor’s beloved mum Becky lay in a small cottage hospice on the Sunshine Coast, her daughter asked: “If you could ...

What did these folks do to deserve to be God's favorites?

Scientists develop a high-performance photoacoustic endoscopy featuring a transparent ultrasound transducer. Recently, a research team consisting of Professor Chulhong Kim from the Department of ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.